Pentagestrone: Difference between revisions
Appearance
Content deleted Content added
No edit summary |
No edit summary |
||
Line 62: | Line 62: | ||
{{Progesterone receptor modulators}} |
{{Progesterone receptor modulators}} |
||
[[Category:Abandoned drugs]] |
|||
[[Category:Ethers]] |
[[Category:Ethers]] |
||
[[Category:Pregnanes]] |
[[Category:Pregnanes]] |
Revision as of 20:41, 29 October 2017
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C26H38O3 |
Molar mass | 398.57812 g/mol g·mol−1 |
3D model (JSmol) | |
| |
|
Pentagestrone (INN ), also known as 17α-hydroxyprogesterone 3-cyclopentyl enol ether, is a steroidal progestin of the 17α-hydroxyprogesterone group that was never marketed.[1][2] An acetate ester, pentagestrone acetate (Gestovis, Gestovister), has been marketed for clinical use.[1] Pentagestrone was described in the literature in 1960.[1]
See also
References
- ^ a b c J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 943–. ISBN 978-1-4757-2085-3.
- ^ Camille Georges Wermuth (2 May 2011). The Practice of Medicinal Chemistry. Academic Press. pp. 731–. ISBN 978-0-08-056877-5.